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Abstract
Background: A growing body of evidence has shown that Krüppel-like transcription factors play a crucial role in
maintaining embryonic stem cell (ESC) pluripotency and in governing ESC fate decisions. Krüppel-like factor 5 (Klf5)
appears to play a critical role in these processes, but detailed knowledge of the molecular mechanisms of this
function is still not completely addressed.
Results: By combining genome-wide chromatin immunoprecipitation and microarray analysis, we have identified
161 putative primary targets of Klf5 in ESCs. We address three main points: (1) the relevance of the pathways
governed by Klf5, demonstrating that suppression or constitutive expression of single Klf5 targets robustly affect
the ESC undifferentiated phenotype; (2) the specificity of Klf5 compared to factors belonging to the same family,
demonstrating that many Klf5 targets are not regulated by Klf2 and Klf4; and (3) the specificity of Klf5 function in
ESCs, demonstrated by the significant differences between Klf5 targets in ESCs compared to adult cells, such as
keratinocytes.
Conclusions: Taken together, these results, through the definition of a detailed list of Klf5 transcriptional targets in
mouse ESCs, support the important and specific functional role of Klf5 in the maintenance of the undifferentiated
ESC phenotype.
See: http://www.biomedcental.com/1741-7007/8/125
Background
Embryonic stem cells (ESCs) are derived from the inner
cell mass of preimplantation embryos; they are amenable
to manipulation, enrichment and expansion and retain
the developmental potency of embryonic founder cells,
being able to differentiate into cells and tissues of all
three germ layers both in vitro and in vivo [1,2]. For
these characteristics, ESCs represent an invaluable
source of different cell types, thus opening up new pos-
sibilities for cell therapy. The understanding of the tran-
scriptional regulatory networks that operate in ESCs is
fundamental to unravel the molecular basis of pluripo-
tency, self-renewal and reprogramming. The complexity
of this regulatory network was highlighted by the
identification of hundreds of genes, targets of the ESC
master genes Oct3/4, Nanog and Sox2 [3,4]. In addition
to these master regulatory factors, several other tran-
scription factors play important roles in the control of
this regulatory network [5-9], such as Krüppel-like fac-
tors (Klfs).
Klfs belong to the Sp1 family of transcription factors
with over 20 members [10,11]. Three members of this
family (Klf2, Klf4 and Klf5) are expressed in undifferen-
tiated mouse ESCs and downregulated during early
stages of differentiation [12]. Klf4 is one of the original
“Yamanaka factors” required to reprogram somatic cells
to a pluripotent state [13], and Klf2 and Klf5 are able to
substitute for Klf4 function in the reprogramming,
including cocktail [14]. It has been proposed that Klf2,
Klf4 and Klf5 have redundant functions because the
impairment in the ESC undifferentiated state was only
observed following knockdown (KD) of all these three
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any medium, provided the original work is properly cited.genes [15]. Nevertheless, there is evidence that Klf5 has
unique functions: We have recently shown that KD of
Klf5 induces ESC differentiation, whereas its ectopic
expression is able to maintain ESC pluripotency in
absence of leukemia inhibitory factor (LIF) [16] and
Klf5-knockout (KO) mice show developmental defects at
the blastocyst stage [17], thus suggesting a specific
requirement of this Klf in early embryogenesis and in
turn a high hierarchical role in the transcriptional net-
work. Opposite to other transcription factors regulating
ESC pluripotency and the first step of embryo develop-
ment, Klfs are also expressed in adult terminally differ-
entiated cells [18]. Klf5 is expressed in skin, intestinal
crypts, stomach, lung, testis, uterus, heart and kidney
[19-21]. We systematically explored Klf5-specific targets
in mouse ESCs by matching gene expression profiling
with chromatin immunoprecipitation coupled with par-
allel short tag-based sequenci n g( C h I P - s e q )t h a ti d e n t i -
fies all Klf5 genome binding sites. Here we report that
Klf5 regulates at least 313 genes functioning as a repres-
sor or activator. A total of 161 of 313 genes bear at least
one binding site for Klf5 within 100 kb from the gene
boundaries, indicating that they can be considered Klf5
primary targets. We first demonstrated that suppression
or ectopic expression of some Klf5 targets strongly
affects the ESC undifferentiated state, thus further sup-
porting a high hierarchical role of this transcription fac-
tor in ESCs. Then we addressed the specificity of Klf5
function in ESCs by demonstrating that Klf2 and Klf4
have nonredundant roles and that Klf5 targets in ESCs
are different from the gene targets of this transcription
factor in adult differentiated cells.
Results
Identification of Klf5 direct targets
To identify genes directly regulated by Klf5, we first
analyzed the transcriptome changes upon Klf5 KD in
ESCs by microarray analysis. To minimize indirect
effects due to phenotypic changes induced by Klf5 KD,
we performed a time course analysis both by qPCR and
by Western blot analysis, which showed that Klf5
expression is significantly decreased already 12 hr after
siRNA transfection (Figure 1a). On the contrary, the
expression of stemness genes such as Oct3/4 and
Nanog, previously demonstrated to be modified by Klf5
KD [16], is still unaffected at 12 hr (Figure 1b). There-
fore, it is possible to capture early effects on transcrip-
tome following Klf5 KD at 12 hr after transfection.
Statistically significant probes (FDR < 0.1) were classi-
fied as upregulated and downregulated following Klf5
KD by using as cut-off > 1.25- and < 0.75-fold changes,
respectively. On the basis of these constraints, we identi-
fied 239 upregulated and 74 downregulated genes (Addi-
tional file 1).
These predicted genes encode a set of proteins
involved mainly in development and differentiation
(Additional file 2), in agreement with the Klf5 role in
ESCs and embryonic development [16,17]. Interestingly,
52 genes controlled by Klf5 encode regulators of tran-
scription, indicating that Klf5 regulates many transcrip-
tion factors, which in turn regulate their downstream
targets. Moreover, among the genes regulated by Klf5,
there are factors that have already demonstrated a role
in ESC pluripotency, such as Tcl1 [8,22], BMP4 [23],
Nr0b1 [24] and CD9 [25]. We also compared our results
with available data [15,17,26,27], and we found that 86
of 96 transcripts showed the same behavior upon Klf5
KD and upon triple KD of Klf2, Klf4 and Klf5 [15]
(Additional file 3). Moreover, we found that 75% of the
transcripts showed the same trend in our analysis and
in Klf4 KD cells [26] (Additional file 3). Instead, no sig-
nificant correlation was found when our data were com-
pared with the data of LIF deprivation or expression of
STAT3 dominant-negative form [27] (Additional file 3).
It is reasonable to assume that Klf5-regulated genes,
identified by gene expression profiling, include both
direct and indirect transcriptional targets. To distinguish
between direct target genes and those indirectly regu-
lated through alterations in transcriptional networks
governed by Klf5, we employed genome-wide chromatin
immunoprecipitation (ChIP). We introduced a FLAG-
tagged Klf5 in ESCs and generated two independent
pools of stable clones. The levels of Klf5 were assessed
by Western blot analysis with anti-Klf5 and anti-FLAG
antibody to detect both endogenous and exogenous Klf5
(Additional file 4). Chromatin from these cells was
immunoprecipitated with anti-FLAG antibody, and puri-
fied DNA fragments were analyzed by direct high-
throughput sequencing. We identified 6480 putative
binding sites, and among these 5820 had an FDR lower
than 5% (Additional file 5). ChIP-qPCR validations were
carried out on 15 Klf5-binding sites with different num-
bers of ChIP tag counts within the defined overlap
region (Additional file 4). Twelve of 15 target loci
subjected to validation showed a significant enrichment
over three independent control regions (Additional
file 4).
Next, we analyzed Klf5-ChIP target sequences with the
motif-finding CisFinder software to search for over-
represented motifs. The three best results were
represented by CG-rich elements (Additional file 6), in
agreement with previous reports [28]. Moreover, all
three motifs contained the CTGC sequence, suggesting
a putative binding site for Klf5.
To identify primary targets of Klf5 among the genes
regulated upon Klf5 KD, we matched microarray and
ChIP-seq data, and we found that the relationship
between target promoter occupancy and gene expression
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whose expression is regulated by Klf5, showing a Klf5
binding site within 100 kb from the gene boundaries
(Table 1, Additional file 5). To validate microarray data
among these 161 Klf5 putative primary targets, we
selected 60 genes where Klf5 binding sites are at various
distances from gene boundaries. qPCR analysis of these
genes performed upon Klf5 KD revealed that 53 (>88%)
of 60 showed the same trend observed in microarray
analysis (Additional file 7).
To gain insights into the primary targets of Klf5, we
analyzed the expression pattern of the 53 validated genes
(Figures 1c and 1d), during neural differentiation of
ESCs. Klf5, such as the other two ESC-specific Klfs, is
Figure 1 Identification of Klf5 targets by microarray analysis. (a) qPCR and western blot analysis of Klf5 expression following transfection of
siKlf5 and siNS at different time points (12, 24 and 48 hr after siRNA transfection). (b) Expression level of stemness markers was measured 12
and 24 hr after transfection by qPCR and Western blot analysis. All qPCR data are expressed as fold changes relative to mock-transfected cells.
Error bars represent standard errors (SD) of triplicates. *P < 0.01. (c and d) Expression of 53 Klf5-target genes measured by real-time PCR in
undifferentiated and 4-day (4 d) and 7-day (7 d) differentiated ESCs. Both Klf5-induced genes (c) and Klf5-repressed genes (d) are reported. The
results are reported as fold changes relative to undifferentiated cells.
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sion dramatically decreases when differentiation occurs
(Additional file 2). We reasoned that genes activated by
Klf5 are expected to show the same expression profile of
Klf5, i.e., expressed in undifferentiated ESCs and downre-
gulated when differentiation occurs. On the contrary, the
genes that are negatively controlled by Klf5 are expected
to show an opposite expression profile, i.e., not expressed
in undifferentiated ESCs and upregulated when differen-
tiation occurs. As expected, almost all the genes activated
by Klf5 are expressed in ESCs and repressed during dif-
ferentiation (Figure 1). On the other hand, almost all the
g e n e st h a ta r ei n a c t i v eo rr e p r e s s e di nE S C s ,b u ta r e
expressed during differentiation, appear to be negatively
regulated by Klf5 (Figure 1d).
Suppression of Klf5 target genes impairs ESC
undifferentiated state
The first point we asked is that of the relevance of Klf5
direct targets in the maintenance of ESC phenotype.
Among the putative Klf5 direct targets, we decided to
start by analyzing 23 genes that were selected on the
basis of validation by qPCR (Additional file 7) and their
expression profile during ESC differentiation (Figure 1).
To this aim, we selected pools of stably transfected ESC
clones, where the expression of these 23 genes was
knocked down by specific shRNAs. A reduction of at
least 20% in transcription levels was observed after
selection (Additional file 8). The stably transfected cells
were plated at clonal density and further grown for 7
days. The resulting colonies were stained for alkaline
phosphatase (AP) activity (Figure 2a) and the percentage
of undifferentiated and differentiated colonies was calcu-
lated. KD of Klf5 (positive control) resulted in at least
40% decrease of AP-positive colonies compared to con-
trol shRNA transfected cells (Figure 2b). Knockdown of
8 of 23 target genes analyzed resulted in a significant
decrease of AP-positive colonies (Figure 2b). To confirm
that these decreases in the number of AP-positive colo-
nies were due to an impairment of ESC undifferentiated
Table 1 List of Klf5-target genes obtained by matching microarray and ChIP-seq data. Klf5-repressed and activated
genes bearing a binding site for Klf5 within 100 kb from gene boundaries are reported
Klf5-repressed target genes Klf5-activated target genes
1110007C09Rik Col5a1 Irx3 Pou3f1 1190005I06Rik F5
1500005I02Rik Cotl1 Itga7 Rasl11b 1200015N20Rik Fgf17
2310045A20Rik Ctgf Itpr1 Rgnef 1600029D21Rik Gjb5
Adam12 Cttnbp2nl Jak2 Runx1 8430410A17Rik Grtp1
Adam19 Dbndd2 Kif21a Sall2 AA409316 Hck
Ankrd1 Dll1 Kif5c Sema3e Abcb1b Igfbp3
Anxa5 Dnmt3a Limd2 Serpine1 Adora1 Klk1b21
Atf3 Dtna Lrrk1 Serpine2 Ap1m2 Krt17
Auts2 Efnb2 Lrrn1 Shroom3 Apobec2 Lamc2
AW548124 Elk3 Ltbp1 Slc22a23 Ass1 Ltbp4
Bach1 Errfi1 Maff Specc1 Bbs2 Mras
Bcar1 Ets1 Mcam Spnb2 Bcam Nedd4l
Bin1 Fads1 Mfhas1 Spop Bmp4 Ngfr
Btg1 Farp1 Mmd St6gal1 Brunol4 Niban
Btg2 Fez2 Mmp2 Syt11 Cd9 Ntn1
C79267 Flt1 Mtap1b Tax1bp3 Cyp2s1 Perp
Cadm1 Foxa1 Mtap7d1 Tgfb1i1 Depdc6 Pura
Cald1 Fzd2 Mycl1 Tgfb2 Dgka Rnase4
Cap2 Gadd45g Myo1b Tmem2 E130012A19Rik Serpinb6c
Ccng2 Gap43 Nfil3 Tmem98 Efemp1 Serpinb9b
Cd248 Gata2 Oaz2 Tpm2 Ehmt2 Sfn
Cd40 Gdnf Otx2 Tshz1 Emp1 Sirt4
Cdc42ep1 Glipr1 Pcdh8 Ugcg Eno3 Tcl1
Cgnl1 Gpsm1 Pcsk2 Wisp1 Epha2 Trim2
Chd7 Hmga2 Pdgfb Yaf2
Cnn1 Hoxb2 Plcg2 Zyx
Cnn2 Igfbp5 Plekhg2
Col1a1 Igfbp7 Pls3
Col1a2 Insm1 Pmp22
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KD for these eight genes soon after selection. Expression
of both Oct3/4 and Nanog was significantly reduced
compared to control after knockdown of all these genes
(Figure 2c). The observed decrease in Oct3/4 and
Nanog expression corresponded to a significant increase
of early differentiation markers (Additional file 9). These
results were confirmed by further independent shRNAs
(Additional file 8). Taken together, these results suggest
that Klf5 controls the expression of at least 8 of 23
Figure 2 Effects of KD of Klf5-target genes in ESCs. (a) ESCs stably transfected with shRNA plasmids were grown for 7 days at clonal density
(50-100 cells/cm
2) and then stained for alkaline phosphatase (AP) activity. The results of shGFP-transfected cells (negative control) and shHck-
transfected cells are shown as examples. Scale bars, 1 cm. (b) Histogram showing the percentages of undifferentiated (blue) and differentiated
(red) colonies observed by AP staining after knockdown of Klf5 response genes. shKlf5-transfected cells are the positive control, and shGFP-
transfected cells are the negative control. Bars represent SD of triplicates. *P < 0.01. (c) qPCR analysis of stemness markers after KD of Klf5 target
genes that induced a significant decrease in AP-positive colonies. Efemp1 KD cells were used as negative controls. The data are represented as
fold changes relative to shGFP-transfected cells. Error bars represent SD of triplicates. Differences are significant with P < 0.01.
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ESCs.
Ectopic expression of Serpine1 impairs ESC
undifferentiated state
As shown above, we found many genes whose expres-
sion in ESCs seems to be negatively regulated by Klf5.
Two of them, Serpine1 and Runx1, were selected for
functional studies. Their Klf5-dependent regulation is
confirmed by the observation that they are expressed at
very low levels in undifferentiated ESCs. Furthermore,
these genes that seem to be negatively regulated by Klf5
in undifferentiated ESCs showed a strong induction
upon ESC differentiation when Klf5 disappeared (Figure
1d) [16]. Thus, we investigated their effect on stemness
by forced expression in undifferentiated ESCs. We trans-
fected ESCs with expression vectors bearing FLAG-
tagged Serpine1 or Runx1 (Figure 3a); these cells, grown
Figure 3 Ectopic expression of Serpine1 impairs ESC undifferentiated state. (a) ESCs were transfected with empty vector (mock) or FLAG-
tagged Runx1 and Serpine1 expression vector. Western blot stained with anti-FLAG antibody show the expression level of FLAG-Serpine1 and
FLAG-Runx1 24 hr after transfection. (b) ESCs transfected with empty vector, FLAG-Serpine1 or FLAG-Runx1 were grown at clonal density (50-100
cells/cm
2) for 7 days and then stained for alkaline phosphatase activity (scale bars, 1 cm). The percentage of undifferentiated (blue) and
differentiated (red) colonies is reported. Bars represent SD of triplicates. *P < 0.05. (c) Expression level of stemness markers was measured 48 hr
after transfection by qPCR. The data are expressed as fold changes relative to mock-transfected cells. Error bars represent SD of triplicates. *P <
0.01. (d) Expression levels of early differentiation markers of ectoderm (Fgf5), endoderm (Sox17) and mesoderm (T, also known as brachyury)
were measured 48 hr after transfection by qPCR. Error bars represent SD of triplicates. *P < 0.01.
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activity. Alkaline phosphatase staining showed that
forced expression of FLAG-Serpine1 is able to induce a
significant decrease in the number of undifferentiated
colonies, whereas FLAG-Runx1-transfected cells did not
show a significant decrease in AP expression (Figure
3b). To further study the effect of forced expression of
Serpine1 and Runx1, we measured the expression level
of Oct3/4 and Nanog. As shown in Figure 3c, the
expression of Oct3/4 was impaired upon Serpine1 con-
stitutive expression in ESCs, and also Nanog showed a
moderate but significant decrease, whereas no significant
changes were detectable in FLAG-Runx1-expressing
cells. This decrease of Oct3/4 and Nanog levels corre-
sponded to a significant increase of early differentiation
markers (Figure 3d) even in the presence of LIF, indicat-
ing that Serpine1 alone is able to impair the undifferen-
tiated state by inducing an uncontrolled differentiation.
ESC-specific targets of Klf5
Next, we asked the question of the specificity of Klf5.
Previous works demonstrated that Klf5 is highly
expressed in skin [19] and that alterations in Klf5
expression level may affect the epidermis-differentiated
phenotype [29], suggesting that Klf5 could regulate the
regenerative potential of stem cells in the epidermis. We
analyzed expression changes of the 53 qPCR-validated
Klf5 targets upon Klf5 KD in primary keratinocytes
(Additional file 10). In fact, we found that the tran-
scripts of six genes expressed in ESCs were not detect-
able in primary keratinocytes, both in Klf5 KD and
control cells, whereas there were 21 of 47 genes simi-
larly regulated by Klf5 in primary keratinocytes and
ESCs. On the other hand, 14 of 47 genes showed oppo-
site changes in ESCs versus keratinocytes, while 12 of
47 genes were regulated by Klf5 only in ESCs (Figure 4).
Although the extent of Klf5 suppression is different in
ESCs versus keratinocytes, the comparison of expression
profiles of these two cells indicated a cell type-specific
gene regulation by Klf5.
A further aspect of the specificity of the Klf5-based reg-
ulation concerns the possibility that Klf2, Klf4 and Klf5
have redundant functions by binding and thus regulating
common targets in ESCs [15]. To address this point, we
investigated gene expression changes of the 53 qPCR-
validated Klf5 targets, following KD of each single Klf.
We transfected Klf2 or Klf4 siRNA in ESCs, and 12 hr
after transfection we found that the level of Klf2 and
Klf4 were significantly reduced, although with different
extent of KD (Additional file 10). In these conditions,
we found that only a low percentage (<10%) of exam-
ined genes showed the same trend upon KD of all these
Klfs (Figure 5). The same low percentage was observed
by comparing Klf5- versus Klf4-regulated genes. Instead,
we found that the genes that showed the same behavior
upon Klf2 and Klf5 KD represent about 40%. Finally, we
observed that about 45% of the genes show a Klf5-speci-
fic gene regulation, different from that dependent on
Klf2 or Klf4 KD (Figure 5), indicating that some redun-
dancy could exist in the genes controlled by Klf5 and
Klf2, rather than Klf4.
Discussion
In the past 3 years, several reports have shown Klf5 to
be an important player regulating ESC self-renewal,
pluripotency and embryonic development with a unique
requirement of Klf5 in inner cell mass (ICM) establish-
ment compared to the other ESC-specific Klfs
[16,17,30-32]. Although the pivotal role of Klf5 in ESC
self-renewal and ICM development has been at least in
part elucidated, its mechanism of action and the genes
that Klf5 controls are still not completely understood. In
the present study, we analyzed Klf5 regulatory targets in
ESCs by comparing microarray and ChIP-seq analysis.
We identified 74 Klf5 target genes whose expression is
activated by Klf5 and 239 whose expression is repressed.
Among them, we found 161 genes bearing Klf5 binding
sites within 100 kb from the gene boundaries and that
can be considered putative primary targets of Klf5.
We have shown that Klf5 controls genes that play a
crucial role in ESCs such as Tcl1 [8,22], BMP4 [23] and
Nr0b1 [24], and thus it may be required in ESCs to
maintain pluripotency by activating expression of these
self-renewal promoting genes and by simultaneously
inhibiting expression of differentiation promoting genes
such as TGFb2 [33], Otx2, Pitx2 [8] and GDNF [34]. To
further support the role of Klf5 in the control of regula-
tors of the ESC phenotype, we have explored the effects
of the suppression of 23 genes target of Klf5. Among
these 23 genes, we identified 8 genes whose KD induces
the loss of ESC undifferentiated state even in the pre-
sence of LIF. The eight identified genes encode cell
adhesion molecules (Bcam, Perp), two protein kinases
(Hck, Dgka), a growth factor binding protein (Igfbp3),
an endoplasmic reticulum protein (Niban) and two pro-
teins with still unknown function (1600029D21Rik,
E130012A19Rik). Such a variety of molecules indicates
that the ability of Klf5 to maintain the ESC undifferen-
tiated state results from the concomitant regulation of a
wide range of cellular activities. These eight genes
showed the same trend of Klf5 expression during ESC
differentiation and, moreover, a different transcriptional
control by Klf2, Klf4 and Klf5 with Igfb3, Niban and
Perp responding only to Klf5. Among these proteins,
Hck has been shown to be involved in gp130-mediated
signaling of LIF, since introduction of constitutively acti-
vated Hck alleviates the requirement of ESCs for LIF to
remain undifferentiated [35]. Our data suggest that Klf5
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specific genes as well as genes whose transcription
seems to be induced upon ESC differentiation. Among
the genes suppressed by Klf5 in undifferentiated ESCs,
we found Serpine1, also known as plasminogen activator
inhibitor-1 (PAI-1). Serpine1 is a downstream target of
TGFb1 and is induced upon ESC differentiation by
TGFb1 stimulation [36]. We have found that ectopic
expression of Serpine1 resulted in an impairment of the
ESC phenotype by promoting the appearance of differ-
entiation markers even in the presence of LIF. This phe-
notype mimics the effect of Klf5 KD as well as of Klf5
KO ESCs [16,17]. Although a redundant function was
suggested for Klf2, Klf4 and Klf5 [15], we have shown
that Serpine1 is regulated specifically by Klf5 and not by
Klf2 and Klf4 suppression. This specific control by Klf5
could explain the inability of Klf2 and Klf4 to compen-
sate for the loss of Klf5 function in ICM establishment.
Klf5 has been described to play a role in various biolo-
gical processes, such as the control of the stress
response in the myocardium [37] and the induction of
somatic cell reprogramming [14]. Furthermore, Klf5 has
many roles in regulating cell cycle, development, prolif-
eration, apoptosis and tumorigenesis [18]. Interestingly,
Sur et al. [29] described a role of Klf5 in the regulation
of the keratinocyte differentiation program and thus in
the regenerative potential of stem cells in the epidermis.
By investigating changes in expression profile of Klf5
target genes both in ESCs and primary keratinocytes, we
have found that Klf5 may work as a repressor or
Figure 4 ESC-specific targets of Klf5. qPCR analysis of expression changes of Klf5 target genes upon Klf5 KD in primary keratinocytes
compared to results obtained in ESCs. Klf5 or NS siRNA were transfected in both primary keratinocytes, and ESCs and gene expression levels
were measured 12 hr after transfection. Probe sets of both genes induced (a) and repressed (b) by Klf5 in ESCs were analyzed. Arrows indicate
genes regulated only in ESCs; arrowheads indicate genes showing an opposite change upon Klf5 KD in ESCs and primary keratinocytes. All data
are expressed as fold changes relative to siNS transfected cells. Error bars represent SD of triplicates.
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of the examined genes seem to be regulated by Klf5 in
an ESC-specific manner, and in many cases the effect of
Klf5 KD in ESCs and primary keratinocytes was oppo-
site. This different regulation by Klf5 could be due to a
different accessibility to transcriptional regulators as a
consequence of chromatin folding and/or to the interac-
tion with cell-specific transcriptional complexes.
Recently, Jiang et al. [15]p r o p o s e dt h a tK l f 5h a sa
redundant function with Klf2 and Klf4 in ESCs. The
same authors showed that there is a greater overlap
between genomic binding sites of Klf2 and Klf4 than
with Klf5. Accordingly, we found that about 45% of the
examined genes are significantly regulated by Klf2 and
Klf5. Interestingly, we also observed that almost half of
the examined genes appear to be regulated specifically
by Klf5. This can explain the unique requirement of
Klf5 for derivation of ESCs and ICM proper develop-
ment [17], in contrast to the dispensable role of Klf2
and Klf4 in these processes [31,32].
Conclusions
Numerous results indicate that Klf5 plays an important
role in maintaining ESC pluripotency and in governing
ESC fate decisions. In this work, we have explored the
mechanisms through which this transcription factor reg-
ulates ESC functions. We have identified a likely com-
plete set of genes, putative primary targets of Klf5 in
E S C s ,b yc o m p a r i n gt h ee a r l yc h a n g e so ft h eg e n e
expression profile induced by Klf5 KD and the results of
Figure 5 Klf5-specific targets. Comparison of gene expression changes following KD of Klf2, Klf4 or Klf5 in ESCs. Klf2, Klf4, Klf5 or NS siRNA
were transfected in ESCs. RNA samples were collected 12 hr after transfection and subjected to qPCR. (a) Klf5-activated genes. (b) Klf5-repressed
genes. Arrowheads indicate the expression changes induced by Klf5 only. All data are expressed as fold changes relative to siNS transfected cells.
Error bars represent SD of triplicates.
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these genes seem to be regulated by Klf5 in an ESC-spe-
cific manner, and Klf5-dependent gene regulation in
ESCs appears to be different from that based on Klf2
and Klf4, two other members of the Krüppel-like family,
previously involved in ESC functions. Finally, we
demonstrated that suppression or constitutive expres-
sion of Klf5 target genes clearly impair the ESC undif-
ferentiated state. These results contribute to the
understanding of the regulatory role of Klf5 in ESCs and
suggest a high hierarchical role in these cells for this
transcription factor.
Materials and methods
Plasmid construction
Serpine1 and Runx1 cDNA were derived from pSport
vector (NIH Mammalian Gene Collection, Open Biosys-
tems, National Institutes of Health, Bethesda, MD, USA)
by PCR [16] with the following oligonucleotides:
HindIII-Serpine1: 5’-GATGACAAGCTTCAGATGTC-
TTCAGCCCTTGCTTGCCTCATCC-3’
NotI-Serpine1: 5’-GGCGATGAGCGGCCGCTCAAG-
GCTCCATCACTTGGCCCATGAAGAGG-3’
HindIII-Runx1: 5’-GATGACAAGCTTGCTTCAGAC-
AGCATTTTTGAGTCATTTCCTTCATATCC-3’
NotI-Runx1: 5’-GGCGATGAGCGGCCGCTCAGTA-
GGGCCGCCACACGGCCTCCTCC-3’
Next, these cDNAs were cloned downstream FLAG-
tag in the p-CBA-FLAG vector by using HindIII and
NotI restriction sites.
Cell culture, transfection, differentiation and alkaline
phosphatase staining
E14Tg2a (BayGenomics, San Francisco, CA, USA) mouse
ESCs were maintained on feeder-free, gelatin-coated
plates in the following medium: GMEM (Glasgow Mini-
mum Essential Medium) (Sigma, St. Louis, MO, USA)
supplemented with 2 mM glutamine, 100 U/ml penicil-
lin/streptomycin, 1 mM sodium pyruvate, 1× nonessen-
tial amino acids (all from Invitrogen, Carlsbad, CA,
USA), 0.1 mM b-mercaptoethanol (Sigma), 10% fetal
bovine serum (HyClone Laboratories, Logan, UT, USA),
and 10
3 U/ml leukemia inhibitory factor (LIF; Millipore,
Billerica, MA, USA). Neural differentiation was induced
as previously described [16]. Briefly, undifferentiated
ESCs were trypsinized into a single-cell suspension and
plated at low density (1-5 × 10
3 cells/cm
2)o ng e l a t i n -
coated dishes in the following medium: knockout Dul-
becco’s minimal essential medium supplemented with
10% knockout serum replacement (both from Invitro-
gen), 0.1 mM b-mercaptoethanol (Sigma), 2 mM gluta-
mine (Invitrogen), 100 U/mL penicillin/streptomycin
(Invitrogen). Medium was changed on alternate days.
Primary mouse keratinocytes were isolated from 2-
day-old Swiss ICR(CD-1) mice (Harlan Laboratories,
Correzzana, Italy) and cultured as previously described
[38]. Transfections were performed 5 days after plating.
Transfection of expression plasmids and shRNA plas-
mids (Open Biosystems; see Additional file 11) both in
ESCs and in primary keratinocytes were performed
using Lipofectamine 2000 (Invitrogen) following the
manufacturer’s instructions. To generate the stable cell
lines, E14Tg2a cells were transfected with shRNA plas-
mids and recombinant clones were selected with Puro-
mycin (Sigma).
For alkaline phosphatase staining, ESCs were cultured
at clonal density (30 cells/cm
2). The cells were fixed in
10% cold neutral formalin buffer (10% formalin, 110
mM Na2HPO4,3 0m MN a H 2PO4 H2O) for 15 min and
then rinsed in distilled water for 15 min. The staining
was obtained by incubation for 45 min at room tem-
perature with the following staining solution: 0.1 M
Tris·HCl, 0.01% naphthol AS MX-PO4 (Sigma), 0.4% N,
N-dimethylformamide (Sigma), 0.06% red violet LB salt
(Sigma).
RNA isolation and qPCR
RNA from ESCs and primary keratinocytes was isolated
by using the Tri reagent (Sigma) and then reverse tran-
scribed using MuMLV-RT (New England Biolabs, Ips-
wich, MA, USA) according to the manufacturer’s
instructions. Real-time RT-PCR was performed using
PRISM 7900HT Sequence Detection System (Applied
Biosystems, Foster City, CA USA) and Power SYBR
Green PCR Master Mix (Applied Biosystems). Gene-spe-
cific primers used for amplification are listed in Addi-
tional file 12.
Microarrays and bioinformatics analysis
Total RNA from ESCs was isolated with Tri reagent
(Sigma) and further purified with the Qiagen column kit
(Qiagen, Milan, Italy). Then samples from three inde-
pendent experiments were sent to Coriell Genotyping
and Microarray Center (Coriell Institute for Medical
Research, Camden, NJ, USA), where, after proper sam-
ple processing, cRNA were hybridized with the Affyme-
trix Mouse Genome 430 2.0 Array (Affymetrix, Santa
Clara, CA, USA).
For bioinformatics analysis, raw probe intensities for
each of the hybridized microarrays were normalized to
gene expression levels using the dChip algorithm [39].
To identify genes significantly responding in the experi-
ment, we computed the P values and false discovery rate
(FDR). A total of 313 probes, corresponding to 313 dif-
ferent transcripts, have been identified (FDR < 0.1 corre-
sponding to P < 0.005) that responded significantly.
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ESCs and primary keratinocytes were lysed in a buffer
containing 1 mM EDTA, 50 mM Tris·HCl, pH 7.5, 70
mM NaCl, 1% Triton protease inhibitor cocktail
(Sigma) and analyzed by Western blot analysis. The
following primary antibodies were used: rabbit anti-
Klf5 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), rabbit anti-Nanog (Calbiochem, San Diego, CA,
USA), mouse anti-Oct3/4 (Santa Cruz Biotechnology),
mouse anti-GAPDH (Santa Cruz Biotechnology) and
mouse anti-FLAG (Sigma). Antibody-protein com-
plexes were detected by HRP-conjugated antibodies
and ECL (both from Amersham Pharmacia, Milan,
Italy).
Chromatin immunoprecipitation
For ChIP-seq analysis, ESCs stably transfected with
FLAG-Klf5 were cross-linked with 1% formaldehyde for
10 min at room temperature, and formaldehyde was
then inactivated by the addition of 125 mM glycine.
Then the chromatin was sonicated to an average DNA
fragment length of 200 to 500 bp. Soluble chromatin
extracts were immunoprecipitated using the mouse
monoclonal anti-FLAG (Sigma) or mouse IgG (Santa
Cruz Biotechnology) as control. Then samples from two
independent experiments were sent to the DNA sequen-
cing service of EMBL (Heidelberg, Germany) and sub-
jected to high-throughput sequencing with Illumina
Genome Analyzer platform (Illumina, San Diego, CA,
USA).
For ChIP-qPCR, samples were prepared as described
above. Supernatant obtained without antibody was used
as an input control. qPCR analyses were performed
using the ABI PRISM 7900HT sequence detection sys-
tem and SYBR Green PCR Master Mix (Applied Biosys-
tems). Primers used for ChIP-qPCR are listed in
Additional file 13.
The amount of precipitated DNA was calculated rela-
tive to the total input chromatin and expressed as the
fold enrichment relative to total input according to the
following formula [40]: fold enrichment = 2{Delta}Ct ×
10, where {Delta}Ct = Ct(input) - Ct(immunoprecipita-
tion), where Ct refers to cycle threshold.
ChIP-seq bioinformatics analysis
More than 13 million sequences were produced and
aligned to the mouse genome (version m37) masked for
DNA repeat by using Bowtie tool version 0.9.9.2 (Center
for Bioinformatics and Computational Biology, Institute
for Advanced Computer Studies, University of Mary-
l a n d ,C o l l e g eP a r k ,M D ,U S A )[ 4 1 ] .A b o u t5 0 %o f
sequences were univocally aligned, and the resulting
coordinates were fed to MACS software version 1.3.5
(Department of Biostatistics and Computational Biology,
Dana-Farber Cancer Institute and Harvard School of
Public Health, Boston, MA USA) [42] to detect genomic
regions enriched for multiple overlapping DNA frag-
ments (peaks) that we considered as putative binding
sites. False discovery rate (FDR) was estimated by
MACS, by comparing the peaks from anti-FLAG sam-
ples with those from control (anti-IgG ChIP) at the
same P value cutoff. Motif analysis was performed by
using CisFinder tool (Developmental Genomics and
Aging Section, Laboratory of Genetics, National Institute
on Aging, NIH, Baltimore, MD, USA) [43] on 200-bp
sequences centered at the expected binding site indi-
cated by peak summit calculated using the MACS tool.
Flanking sequences 1000 bp away from the peak summit
have been used as control sequences.
Additional material
Additional file 1: Additional Table 1. Gene expression profile by
microarray analysis upon Klf5 KD in ESCs. Fold change is calculated by
comparing data from siKlf5 cells over the control (siNS). Cut-off >1.25-
and <0.75-fold changes were used. Probes with FDR <0.1 were selected.
Additional file 2: Additional Figure 1. GO analysis of Klf5 targets and
Klf expression profile during ESC differentiation. (a) Gene ontology (GO)
annotation of the selected probe sets according to DAVID “Biological
Process Classification” tool (Laboratory of Immunopathogenesis and
Bioinformatics, Clinical Services Program, SAIC-Frederick, Inc., National
Cancer Institute at Frederick, Frederick, MD, USA). (b) Expression levels of
Klf2, Klf4 and Klf5 were measured by qPCR in undifferentiated (t0) and 4-
day (4d) and 7-day (7d) differentiated ESCs. The data are represented as
fold changes relative to undifferentiated cells.
Additional file 3: Additional Table 2. Microarray data were compared
with published results. Column siKlf5/siNS is referred to our microarray
data (see also Additional Table 1). Differences with published data are
highlighted in red. dw: downregulated gene, up: upregulated gene; na:
data not available.
Additional file 4: Additional Figure 2. ChIP-seq validation by ChIP-
qPCR. (a) Expression level of FLAG-Klf5 stable clone pools used to
prepare chromatin for ChIP-seq experiment. Western blot was stained
with an anti-FLAG and anti-Klf5. (b) List of peaks validated by ChIP-qPCR.
Peaks with different numbers of tags were chosen. Peak location are
indicated (chr, chromosome). (c) ChIP-seq validation was performed by
ChIP-qPCR using anti-FLAG antibody and IgG, as control, with extracts
derived from FLAG-Klf5 and Mock transfected ESCs. The data are
expressed as the amount of precipitated DNA calculated relative to the
total input chromatin. Samples from 1 to 15 correspond to regions close
to the following genes: Agap1, Lamc2, Fcgr3, 170009P17Rik, Tgfbβ2,
Smx16, Nlgn1, Epha2 (upstream region), Epha2 (downstream region),
Igfbp7, Serpine1, Cyp2s1, 4930467E23Rik, AC152164, Inpp4b, respectively.
Three different control regions were chosen (samples 16, 17 and 18):
chr1:10573933-10573984, chr1:71481391-71481461, chr3:12034661-
12034625, respectively, where no significant peaks were found. Bars
represent SD of triplicates.
Additional file 5: Additional Table 3. Results of ChIP-seq analysis. The
putative binding sites of Klf5 are reported with relative number of tags
for each peak and FDR. Match with gene microarray data is shown. The
distance from the 5’ and 3’ boundaries of the Klf5-regulated genes is
indicated.
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Page 11 of 13Additional file 6: Additional Figure 3. Klf5 binding motifs identified
with CisFinder via 200-bp sequences centered at binding peaks (E-score
> 22).
Additional file 7: Additional Figure 4. qPCR validation of microarray
data. Sixty Klf5 target genes were analyzed by qPCR to confirm the
microarray data. Probe set of both downregulated (a) and upregulated
(b) genes upon Klf5 KD is shown. Black bars represent not validated
probes. The data are expressed as fold change relative to siNS
transfected cells. Validated probes showed a P < 0.01.
Additional file 8: Additional Figure 5. KD of a subset of Klf5-target
genes. (a) ESCs were stably transfected with shRNA plasmids for selected
Klf5-target genes or with control shRNA (shGFP) and KD was verified by
qPCR. The results are represented as fold changes relative to shGFP-
transfected cells. SD of triplicates is reported. (b) Percentage of
undifferentiated (blue) and differentiated (red) colonies observed by AP
staining upon KD of eight Klf5-target genes with a second independent
shRNA. *P < 0.01. (c) Expression levels of Oct3/4 and Nanog upon KD of
eight Klf5-target genes with a second independent shRNA. The data are
represented as fold changes relative to shGFP-transfected cells.
Additional file 9: Additional Figure 6. Expression of early
differentiation markers of endoderm (Sox17), mesoderm (Brachyury) and
ectoderm (Fgf5) upon KD of eight Klf5-target genes.
Additional file 10: Additional Figure 7. Klf5 KD in primary
keratinocytes and Klf2 and Klf4 KD in ESCs. (a) Klf5 or NS siRNA were
transfected in primary keratinocytes and Klf5 expression level was
measured 12 hr after transfection by Western blot with anti-Klf5
antibody. (b) Expression levels of Klf2, Klf4 and Klf5 were measured by
qPCR in ESCs 12 hours after siRNA transfection. The results are
represented as fold changes. Bars represent SD of triplicates. P < 0.01.
Additional file 11: Additional Table 4. Sequences of shRNAs.
Additional file 12: Additional Table 5. Primers used for qPCR.
Additional file 13: Additional Table 6. Primers used for ChIP-qPCR.
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